Results 121 to 130 of about 94,230 (262)

Bronchopulmonary dysplasia and patent ductus arteriosus in infants ≤32 weeks of gestational age. [PDF]

, 2016
Topic: Bronchopulmonary dysplasia and patent ductus arteriosus in infants ≤32 weeks of gestational age. Purpose: The impact of patent ductus arteriosus on the frequency of development of bronchopulmonary dysplasia in infants ≤32 weeks of gestational age.
Stasiūnaitė, Monika
core  

Born early, age fast: Consequences of premature birth on chronic disease and accelerated ageing

The Journal of Physiology, EarlyView.
Abstract figure legend ELGANs are exposed to several postnatal pro‐oxidant stressors, including ambient and supplemental oxygen, mechanical ventilation, infections, hyperalimentation, excessive glucocorticoids and intermittent hypoxia. Since endogenous antioxidant defences are underdeveloped, this imbalance promotes oxidative stress and inflammation ...
Estelle B. Gauda, Julijana Ivanovska, Dwayne Mascarenhas, Jeffrey Antwi, Atefeh Mohammadi, Bonny Jasani   +5 more
wiley   +1 more source

Bronchopulmonary dysplasia - 5 years retrospective analysis in Júlio Dinis Maternity Hospital [PDF]

, 2003
Bronchopulmonary dysplasia remains a pathology of concern, with significant morbidity and mortality, but since Northway et al‘s original description the concept has been changing. The authors made a review of the cases of bronchopulmonary dysplasia
Almeida, A., Mesquita, S., Proença, E., Miguez, M.   +3 more
core  

Expanded Phenotype Associated With an Intronic PPP1R12A Variant: A Case Report and Literature Review

American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2519-2524, November 2026.
ABSTRACT Autosomal dominant PPP1R12A‐related genitourinary and/or brain malformation syndrome is a recently described multisystem disorder caused by loss‐of‐function variants in the protein phosphatase 1 regulatory subunit 12a (PPP1R12A) gene. To date, 22 affected individuals have been reported with variable brain malformations and genitourinary ...
Emily M. Bland, Amber Nakar Weinstein, Eric C. Kao, Xiaonan Zhao, Monika Weisz‐Hubshman   +4 more
wiley   +1 more source

Inhaled Drugs and Systemic Corticosteroids for Bronchopulmonary Dysplasia

, 2017
All definitions of bronchopulmonary dysplasia (BPD) have limitations and a new definition for the purpose of clinical research, benchmarking, and prognostic prediction is needed. Different inhaled and systemic drugs are currently used to prevent or treat
van den Anker, John N., Dirk Bassler, van den Anker, John, John van den Anker, Bassler, Dirk, Bassler, D., Bassler D, van den Anker J   +7 more
core   +1 more source

A Case of Multiple Mitochondrial Dysfunctions Syndrome 1 and Review of the Literature

American Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2409-2419, November 2026.
ABSTRACT Multiple mitochondrial dysfunctions syndrome 1 (MMDS1, MIM #605711) due to NFU1 gene defects is an ultra‐rare autosomal recessive inborn error of metabolism associated with reduced function of NFU1 iron–sulfur cluster (ISC) scaffold protein.
Charles R. DiFalco, Aaron Williams, Claudia Soler‐Alfonso, Emily Waskow, Elizabeth Mizerik, Fernando Scaglia, Chaya N. Murali   +6 more
wiley   +1 more source

Characteristics of Speech Sound Development in Preterm‐Born Children: A Scoping Review

International Journal of Language &Communication Disorders, Volume 61, Issue 6, November/December 2026.
ABSTRACT Background There is substantial evidence for the detrimental impact of preterm birth on language development compared to children born at term. However, little is known regarding speech sound development of preterm infants. Speech development precedes language development and requires investigation in its own right.
Sam Burr, Sam Harding, Sarah Rudd
wiley   +1 more source

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AS A SIDE-EFFECT OF DEXAMETHASONE TREATMENT FOR BRONCHOPULMONARY DYSPLASIA

, 1993
We report three infants who developed hypertrophic obstructive cardiomyopathy during dexamethasone treatment for bronchopulmonary dysplasia. In all three infants, echocardiography had ruled out cardiac abnormalities prior to the dexamethasone course. The
BRAND, PLP; id_orcid, VANLINGEN, RA, TALSMA, MD, BRUS, F, BRAND, PLP, ELZENGA, NJ   +5 more
core  

The New Era of Respiratory Syncytial Virus Protection for Infants: A Mini Review of Current Tools for Immunoprophylaxis

Acta Paediatrica, Volume 115, Issue 11, Page 2466-2472, November 2026.
ABSTRACT Aim This mini review describes the history of infant respiratory syncytial virus (RSV) immunoprophylaxis and the latest advances in this area. It also reviews the efficacy, safety and impact of the recently introduced prophylactic strategies. Method This narrative review is based on a targeted review of published literature, with emphasis on ...
Santtu Heinonen, Pekka Vartiainen
wiley   +1 more source

INHALANT GLUCOCORTICOID APPLICATION EXPERIENCE AMONG INFANTS WITH BRONCHOPULMONARY DYSPLASIA IN THE FIRST HALF YEAR OF LIFE

Педиатрическая фармакология, 2008
The article describes the modern views on the application of the inhalant glucocorticoids (budesonide suspension) among infants, who underwent artificial pulmonary ventilation at the neonatal stage and who had bronchopulmonary dysplasia formed.
I.V. Davydova, G.V. Yatsyk, O.F. Lukina, O.V. Tresorukova   +3 more
doaj   +2 more sources